Shanghai-Developed Global First-in-Class Drug Dorzagliatin Tablets Approved for Market Launch

Gelonghui October 8th丨According to The Paper, recently, the National Medical Products Administration approved the listing of Hua Medicine's Class 1 innovative drug, Dorzagliatin Tablets (brand name: Huatangning). This medicine is suitable for improving blood glucose control in adult patients with type 2 diabetes.